Which Medical Device - Expert Independent Opinion
For more than 50-years, Cordis, a Johnson & Johnson company, has been a recognised world leader in cardiovascular research and development. Cordis continues to pioneer minimally invasive treatments for cardiovascular disease and is committed to delivering the right combination of products and services supported by clinical evidence to help optimise patient outcomes. Cordis educational support to physicians includes a comprehensive programme under the banner of CCVI (Cordis Cardiac & Vascular Institute – for more information, go to: ccvi-online.com).
The company has a strong commitment to evidence-based medicine with a record of leadership in funding major trials that have significantly improved circulatory disease management across all indications. Cordis has led the way in developing and establishing intravascular stenting as an effective treatment option for patients with circulatory disease.
No Editor Review
No Ratings
CYPHER® Stents are specifically designed to reduce in-stent restenosis. CYPHER® Stents are small, spring-like metal stents coated with the drug sirolimus. The drug-eluting stents also include a polymer coating that controls the timed release of the drug inside the vessel. Since its...
read full description
No Ratings
The ExoSeal(TM) Vascular Closure Device from Cordis Johnson and Johnson makes use of key technological developments to support the clinical safety* and efficacy of the closure procedure. In the ECLIPSE Trial , the extravascular plug placement was associated with no embolisation, infection...
read full description
No Editor Review
The Optease filter is a retrievable filter that can be inserted via femoral, jugular or antecubital routes. The filter comes compressed in a plastic tube for insertion, marked for the appropriate insertion route. This nitinol hypotube filter is a modified version of the permanent TrapEase...
read full description
No Editor Review
The Cordis OUTBACK® LTD™ Re-Entry Catheter is designed to “get back into the true lumen with ease and precision” at the reconstitution point to ensure optimal patient outcomes. The OUTBACK® helps to reduce radiation exposure time 1 and on average re-entry takes...
read full description
No Editor Review
No Ratings
The TRAPEASE Permanent Vena Cava Filter from Cordis is designed for the treatment and prevention of recurrent pulmonary embolism. The filter is deployed via a 6F sheathed induction kit. The updated temporary version is the OptEase filter. 'A brief history of inferior...
read full description
